Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery
View abstract on PubMed
Summary
This summary is machine-generated.The neutrophil-lymphocyte ratio (NLR) and albumin-globulin ratio (AGR) can predict breast cancer treatment response and patient outcomes. Higher AGR and lower NLR are associated with better survival and treatment efficacy.
Area Of Science
- Oncology
- Immunology
- Biochemistry
Background
- The neutrophil-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with poorer cancer prognosis.
- The albumin-globulin ratio (AGR) may reflect nutritional status and immune function, potentially indicating a better prognosis.
Purpose Of The Study
- To investigate the association between NLR, AGR, and treatment response and survival in breast cancer patients.
- To determine the prognostic value of NLR and AGR in different breast cancer treatment settings.
Main Methods
- Retrospective analysis of 1,188 patients with stage I-III breast cancer (2011-2017).
- Multivariate logistic regression and Cox regression analyses were used to assess NLR and AGR in relation to treatment outcomes and survival.
- Patients were stratified based on neoadjuvant chemotherapy (NACT) or upfront surgery.
Main Results
- In NACT patients, higher AGR correlated with increased pCR rates, improved DFS, and CSS. Higher NLR was linked to worse DFS and CSS.
- In upfront surgery patients, higher AGR was associated with better OS, while higher NLR correlated with worse OS.
- Specific cut-off values for NLR and AGR were identified for predicting outcomes in both treatment groups.
Conclusions
- NLR and AGR serve as valuable predictive markers for neoadjuvant chemotherapy response and overall prognosis in breast cancer.
- These ratios may aid in clinical decision-making, although further research is warranted.

